Determination of Acaricide Resistance in Rhipicephalus (Boophilus) microplus (Acari: Ixodidae) Field Populations of Argentina, South Africa, and Australia With the Larval Tarsal Test by Lovis, L. et al.
VECTOR CONTROL, PEST MANAGEMENT, RESISTANCE, REPELLENTS
Determination of Acaricide Resistance in Rhipicephalus (Boophilus)
microplus (Acari: Ixodidae) Field Populations of Argentina, South
Africa, and Australia With the Larval Tarsal Test
L. LOVIS,1,2,3 J. REGGI,4 M. BERGGOETZ,1 B. BETSCHART,1 AND H. SAGER2
J. Med. Entomol. 50(2): 326Ð335 (2013); DOI: http://dx.doi.org/10.1603/ME12127
ABSTRACT Infestationswith ticks have an important economic impact on the cattle industryworldwide
and resistance to acaricides has become a widespread phenomenon. To optimize their treatment strategy,
farmersneedtoknowifandagainstwhichclassespotentialacaricide-resistancedoesoccur.Bioassaysareused
to assess the resistance level and pattern ofRhipicephalus (Boophilus) microplus populations. The objective
of thecurrent studywas toassess the susceptibilityofÞeldpopulationsoriginating fromArgentina(8), South
Africa (3), andAustralia (2) using theLarval Tarsal Test.Nine acaricidal compounds fromÞvemajor classes
were tested: organosphosphates, synthetic pyrethroids (SP), macrocyclic lactones, phenylpyrazols, and
amidines. The resistance ratios at concentrations inducing 50 and 90% mortality were used to detect
establishedandemergingresistance.This studyconÞrmedthenewlyreportedpresenceofamitrazresistance
in populations from Argentina. In addition, resistance to SP appeared to be widespread (88%) in the
Argentineanfarms,whichhadbeenselectedbasedontheobservationoflackoftreatmentefÞcacybyfarmers.
InSouthAfricaoneofthethreepopulationswasfoundtoberesistanttoSPandtoaphenylpyrazolcompound
(pyriprol). Furthermore, resistance to organosphosphates and SP was observed in Australia. Finally, the
Larval Tarsal Test proved to be a suitable test to evaluate the susceptibility ofR.microplus Þeld populations
to the most relevant acaricidal classes.
RESUMEN Las infestaciones por garrapatas tienen un importante impacto econo´mico en la industria del
ganadode todoelmundoy la resistencia a los acaricidas sehaconvertidoenun feno´menogeneralizado.Con
el Þn de optimizar la estrategia de los tratamientos, los ganaderos necesitan saber en contra de cua´les clases
de acaricidas ocurre esa potencial resistencia. Se utilizan bioensayos para evaluar el patro´n y nivel de
resistencia de Rhipicephalus (Boophilus) microplus. El objetivo del presente estudio fue evaluar la suscep-
tibilidad de poblaciones de campo procedentes de Argentina (8), Suda´frica (3) y Australia (2) usando la
prueba del tarso de las larvas (LTT). Nueve compuestos acaricidas de cinco clases principales: organofos-
forados(OP),piretroides sinte´ticos(SP), lactonasmacrocõ´clicas(ML), fenilpirazoles(PYZ)yamidinas.Para
detectar resistenciaestablecidayemergente, secalcularonnivelesde resistenciabasadosenconcentraciones
que inducenmortalidad a 50%y 90%.Este estudio conÞrma la nueva denuncia de la presencia de resistencia
al amitraz en las poblaciones de garrapatas de Argentina. Adema´s, la resistencia a SP parece estar muy
difundida (88%) en los establecimientos argentinos, seleccionados sobre la base de la observacio´n de los
ganaderos, de la faltadeeÞcaciade los tratamientos.EnSuda´frica, enunade las trespoblaciones, seencontro´
que era resistente a SP y a un compuesto PYZ (pyriprol). Adema´s, resistencia a OP y SP fue observada en
Australia. Finalmente, la LTT ha demostrado ser un ensayo adecuado, para evaluar la susceptibilidad de
poblaciones de campo de R. microplus a las clases acaricidas ma´s relevantes.
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Ticks are themajor limiting factor to cattle husbandry
in many tropical and sub-tropical areas and cause
important economic losses (Graf et al. 2004). Among
them, the southern cattle tick Rhipicephalus (Boophi-
lus) microplus (Canestrini) has developed resistance
to all the available classes of acaricides with the ex-
ception of the growth regulators and the naturalytes
(Kempet al. 1998,FAO2004,CastroÐJaneret al. 2011).
North-Argentina is at the southern limit of its distri-
bution inLatinAmerica, andcattle ticks tend to spread
toward south despite the current eradication program
(dÕAgostino 2010). In 1992, nine million cattle were
estimated to be infested with R. microplus ticks (Gug-
lielmone 1992) and total losses were estimated to be
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over 150 million United States dollars (Spa¨th et al.
1994). However, few reports of acaricide resistance in
Argentina are available in the literature. Resistance to
organophosphates (OP)wasÞrst reported in the1970s
(Grillo Torrado and Gutie´rrez 1970, Grillo Torrado
and Pe´rez Arrieta 1977) while synthetic pyrethroid
(SP) resistance was Þrst identiÞed in 1996 in Argen-
tina (Caracostanto´golo et al. 1996) and then repeat-
edly reported in the 2000s (Mangold et al. 2004, Gug-
lielmone et al. 2006). The Þrst case of amitraz
resistancewas very recently described in the province
of Corrientes (Cutulle´ et al. 2013). There is also only
little information available on acaricide-resistance of
R. microplus in South Africa. Its resistance to OP was
Þrst reported in 1979 (Baker et al. 1979). Later, resis-
tance to SP and to amitraz have also been identiÞed in
Boophilus spp., Þrstly without distinction of the spe-
cies (Kemp et al. 1998, Strydom and Peter 1999, de
Bruin 1999) and in 2008 in R. microplus (Ntondini et
al. 2008). In Australia, R. microplus was introduced
accidentally with imported cattle, probably before
1870 (Angus 1996, Graf et al. 2004) and spread since
then to the northern and the eastern part of the coun-
try (Cutulle´ et al. 2009). Acaricide resistance in Aus-
tralia is well documented. Resistance to OP appeared
in themid-1960s (Shaw andMalcolm 1964, Shaw 1966,
Roulston et al. 1968) and was widespread by the mid-
1970s (Roulston et al. 1981). Resistance to SP ap-
peared in the late 1980s (Nolan et al. 1989) and in-
creased rapidly (Kempet al. 1998, Jonsson et al. 2000).
In comparison, amitraz resistance, which appeared in
theearly 1980s (Nolan1981), spread inAustraliamuch
more slowly (Kemp et al. 1998, Jonsson et al. 2000,
Jonsson and Hope 2007). To our knowledge, no re-
sistance tomacrocyclic lactones (ML) or phenylpyra-
zol (PYZ) compounds has ever been reported in any
of these three countries.
Various bioassays are used to evaluate tick suscep-
tibility, such as the adult immersion test (AIT) (FAO
2004), the larval packet test (LPT) (FAO 2004) and
the larval immersion test (LIT) (Shaw 1966, Sabatini
et al. 2001). More recently a new bioassay, the larval
tarsal test (LTT), was developed and compared with
the LPT and was shown to be equally sensitive to
detect resistance to coumaphos, SPandamitraz (Lovis
et al. 2011). The advantage of the LTT is to allow
testing a large number of compounds and doses in
little time and with a small number of engorged fe-
males.
The objective of the current study was to apply the
LTT to Þeld populations originating from Argentina,
South Africa, and Australia to assess their susceptibil-
ity tonine compounds fromÞvemajor classes (OP, SP,
ML, PYZ, and amidines).
Materials and Methods
Tick Strains. The Mun˜oz strain was used as the
susceptible reference strain. This strain was collected
during an outbreak in Zapata County, Texas, in 1999.
It was then established and reared without acaricide
selection at the Cattle Fever Tick Research Labora-
tory (CFTRL), Edinburg, TX. Some larvae of the F48
generation were transferred to the Novartis Animal
Health Research Center (CRA), St-Aubin, Switzer-
land in 2010 to establish a colony. Ticks used for the
bioassays were from F49 and F50 generations.
Engorged females were collected in Argentina,
South Africa, and Australia and were shipped to Swit-
zerland for in vitro testing at CRA. ARGENTINA: In
November 2010, eight R. microplus samples were col-
lected from seven beef cattle farms of the province of
Corrientes, northÐeast Argentinawhere farmerswere
complaining about some lack of treatment efÞcacy.
The samples contained 13Ð41 engorged females col-
lected from 6 to 15 infested cows andwere originating
from the following fourmunicipalities: Loreto (ST27),
Saladas (ST21, ST22), Santo Tome´ (ST24, ST26, ST29,
and ST30), and Virasoro (ST25) (Fig. 1A). Ticks from
ST21 and ST22 were considered as two separate pop-
ulations although they were collected on the same
farm. The cattle from which the ticks were collected
were geographically remote and had been treated
with compounds of distinct acaricidal classes. SOUTH
AFRICA: InFebruary andApril 2010, three samples of
10Ð40 engorged females of R. microplus were ob-
tained from South Africa. R. microplus was morpho-
logically differentiated from Boophilus decoloratus
(Koch) at collection using a stereomicroscope (Walker
et al. 2003).Twosampleswerecollected fromcattleheld
on communal lands where cattle belong to several
owners, as it is common in the local African traditions
(Pleetenberg Bay area, Western Cape (ST11) and
Eglington, Hluvukani area, Mpumalanga (ST15). The
Fig. 1. Locations of the populations collected in (A) Argentina (Province of Corrientes), (B) South Africa (Provinces
of Western Cape and Mpumalanga), and (C) Australia (State of Queensland).
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thirdpopulation (ST12)originated fromacommercial
beef cattle farm located in Pleetenberg Bay, Western
Cape (Fig. 1B). Populations originating from South
Africa and Argentina were intended to be tested in
vitro on arrival in Switzerland without being previ-
ouslymaintained on calves. AUSTRALIA: InFebruary
2009, engorged females ofR.micropluswere collected
in two beef cattle farms from Mount-Urah and Curra
municipalities, Queensland, Australia (Fig. 1C) and
shipped to the CRA to establish a colony that was
maintained without acaricide selection. F3 and F4
generations were used for in vitro testing of the Urah
and Curra strain, respectively.
For the shipment, engorged females were placed in
glass tubes with meshed lids hold in a soft structure
and kept in a polystyrene box containing a piece of
cloth soaked with distilled water to ensure sufÞcient
humidity. Thepolystyrene boxwas placed in a foamed
box protected by a cardboard. On arrival in the CRA,
ticks were moved to larger containers and maintained
at 28  1C and 80% relative humidity (RH) to com-
plete oviposition. Eggs were used for in vitro testing
around a week before hatching (F1 generation). For
two strains (ST11 and ST12), the use of perforated
Falcon tubes instead of glass tubes negatively im-
pacted the preservation of the eggs laid during ship-
ment. On arrival in the CRA, the remaining healthy
eggs were allowed to hatch and larvae were used to
infest a calf. The resulting engorged females produced
a sufÞcient number of healthy eggs (F2 generation)
for in vitro testing.
Acaricides. Technical grade coumaphos (OP), di-
azinon (OP), cypermethrin (SP), ßumethrin (SP),
ivermectin (ML), moxidectin (ML), Þpronil (PYZ),
pyriprol (PYZ), and amitraz were used in this study.
Details on these compounds are available in Lovis et
al. (2011).Technical gradecompoundsweredissolved
in dimethyl sulfoxide (DMSO; Fluka, Switzerland) to
prepare stock solutions at 20,000 parts per million
(ppm).
Larval Tarsal Test (LTT).The LTT was carried out
as described previously (Lovis et al. 2011). Brießy, 20
l of a coating solution containing 100% ethanol and
0.25% of olive oil (SigmaÐAldrich, Fluka, Switzerland)
was dispensed into each well of ßat bottom 96-well
plates (NUNC, Catalog No. 260836, Denmark) and
ethanol was allowed to evaporate overnight under a
fume hood. Then, a top dose of each acaricidal com-
poundwas prepared inDMSO from the stock solution
and12 two-folddilutionswere subsequentlyprepared.
A volumeof 5l of each dilutionwas dispensed on the
bottom of the corresponding wells of the microtiter
plates, that is, a concentration of 566 ppm corre-
sponded to 100 mg/m2. The upper and lower rows as
well as one of the inner rows of the plates always
contained 5 l of DMSO only. This set-up allowed
testing Þve compounds per plate and each concen-
tration was tested in triplicates on three separate
plates. The inner rows containing only DMSO were
used as a control. DMSO was evaporated either by
using an N2 sampler concentrator (Techne DB-3 Dri-
Block, Witec AG, Switzerland) or a centrifugal vac-
uum concentrator (SC21017 SpeedVac Plus, Thermo-
Savant).
Plates were used for testing within 3 d after prep-
aration. Around 50 eggs were distributed per well
using a seed counter (elmor, Switzerland). Plates
were incubated for 24 h at 28  1C and 95% RH
before being sealed with a transparent sealing Þlm
(VIEWseal, Greiner bio-one, Switzerland). Sealed
plates were then placed at 28 1C and 70Ð80% RH.
Plates were removed from the environmental cham-
ber around 2 wk after hatching and larval mortality
was evaluated by counting dead or alive larvae using
a stereomicroscope.Larvalmotility andglobal appear-
ance were used as criteria to assess mortality.
The Argentinean populations were all tested with
the nine selected compounds except ST30 that was
tested with only one compound of each class because
of a limited number of ticks available. The Australian
and South African populations were tested with the
same nine compounds except diazinon that was not
tested. All the compounds were tested at the same
concentration range (0.05Ð100 mg/m2) for the two
Australian strains. This range was adapted for the
Argentinean and South African populations and the
following concentrations were tested: Þpronil, ßu-
methrin, pyriprol: 0.003Ð6.25 mg/m2; moxidectin:
0.05Ð100 mg/m2; ivermectin: 0.05Ð100 or 0.2Ð400
mg/m2; cypermethrin: 0.2Ð400 mg/m2; amitraz: 0.1Ð
200 or 0.4Ð800 mg/m2; coumaphos, diazinon: 0.4Ð
800 mg/m2.
Statistical Analysis.Datawere entered inExcel soft-
ware (Microsoft OfÞce 2003) and transferred to In-
tercooled STATA release 11.0 (StataCorp, College
Station, TX). All mortality values were normalized by
the mortality of the DMSO control wells using Ab-
bottÕs formula (Abbott 1987). Outer wells of the mi-
croplates with increased mortality because of edge
effects in plates were removed. The R software (ver-
sion 2.12.0) was used for statistical analysis using the
drc package (version 2.0Ð1), speciÞc for modeling
doseÐresponse curves (Ritz and Streibig 2005). Dose-
mortality data were modeled using a Þve-parameter
log-logistic function (drm command) with the lower
and upper limits locked at 0 and 100, respectively.
Doses inducing 50% mortality (LC50), LC90, and LC99
and their 95% CI were estimated with the ED com-
mand using the delta option. Resistance ratios based
on the LC50 (RR50) and on the LC90 (RR90) were
calculated in reference to the susceptible Mun˜oz
strain using the SI command and the delta interval for
their 95% CI. Resistance ratios were considered sig-
niÞcant if their 95%CI did not include 1. Three classes
based on RR values were created to emphasize the
increasing resistance intensity. Populations were con-
sidered susceptible to a speciÞc compound when the
RR was smaller or equal to 4, moderately resistant for
4RR10 and highly resistant for RR10. Potential
discriminating doses (DD) were calculated as 2 
LC99 of the susceptible reference strain (Jonsson et al.
2007). The survival rates of the Þeld strains at the DD
were predicted using the PR command. Discriminat-
ing doses were not generated for amitraz as the use of
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a single DD is not recommended for this compound
(FAO 2004, Jonsson et al. 2007, Lovis et al. 2011).
Results
Doses inducing 50 and 90%mortality aswell as their
95% CI are displayed in Tables 1Ð5. The susceptible
Mun˜oz strain was used as reference for comparison
with the Þeld populations and RR50, RR90 as well as
their 95% CI are also available (Tables 1Ð5). In addi-
tion, Tables 1Ð4 include the survival rates of the Þeld
populations at the DD.
The 95% CI of LC90 and of RR90 were wider than
those calculated for LC50 and RR50. Resistance sta-
tuses were, therefore, established based on RR50, and
then compared in the discussion to those based on
RR90. Some discrepancy was observed between the
ability of the two estimates to detect resistance in case
of absence of parallelism between the doseÐresponse
curvesof theÞeldpopulations and the reference strain
as illustrated in Fig. 2 for ßumethrin and amitraz.
Resistance Status by Country Based on RR50. In
Argentina, onecaseofmoderate resistance todiazinon
(RR50  5.4, 4.7Ð6.1) was recorded, while all the
populations were susceptible to coumaphos. Resis-
tance to SP was the most common. Cypermethrin
resistance was detected in all the populations except
one (88%) with RR50 ranging from 4.2 (2.5Ð5.9) to
57.0 (37.5Ð76.5). In addition, two of these populations
also demonstrated resistance to ßumethrin based on
RR50. Finally, all the Argentinean populations were
shown to be susceptible to ML and PYZ, while resis-
tance to amitraz was observed in three of the eight
populations (38%) with RR50 ranging between 9.0
(5.9Ð12.1) and 32.5 (24.1Ð40.8). Analysis of the three
populations originating from South Africa revealed
that two of them (ST11, ST12) were susceptible to all
compounds while the third one (ST15) was consid-
ered as highly resistant to SP (RR50  101.5, 72.4Ð
130.6) and moderately resistant to pyriprol (RR50 
9.9, 6.0Ð13.9). Finally the two Australian populations
showed similar resistance proÞles to the nine tested
compounds, both being moderately resistant to cou-
maphos and highly resistant to SP while they were
susceptible to all other compounds.
Discriminating Doses. Survival rates at the DD of
the resistant populations (based on RR50) were all
10%, ranging from 16.1 to 87.1%. A single exception
was observed with ST27 when tested with diazinon
(5.2% survival at DD). Survival rates at the DD of the
susceptible populations (based on RR50) were below
10%with the following Þve exceptions out of 108 tests:
ST30 tested with coumaphos (15.2% survival at DD);
ST22, ST25, ST26, and ST27 tested with ßumethrin
(survival rates between 26.1 and 34.5% at DD).
Discussion
The concentrations of the acaricidal compounds
thatwere tested in this studywere suitable tocalculate
LC50 andLC90 of susceptible and resistant populations
in 97% of the tests. The remaining 3% consisted of :
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ST11, ST12, and ST21, for which the tested doses of
ßumethrin were not sufÞciently low to allow deter-
mining the LC50 and LC90 and the estimates could not
be extrapolated from the model; Urah, for which the
LC90 to cypermethrin was slightly above the highest
tested dose and the estimate was therefore extrapo-
lated from the model (Table 2).
In general, the RR50 was the method of choice to
determine the resistance status because their 95% CI
was smaller compared with RR90. However, RR90 is
complementary to RR50 when the doseÐresponse
curvesof theÞeldpopulations and the reference strain
arenot parallel. A smaller slopeof theÞeldpopulation,
which leads toRR90 greater thanRR50, is an indicator
that resistance is developing and that the population
is heterogeneous, with susceptible and resistant indi-
viduals (FAO 2004). Therefore, RR90 has to be con-
sidered to detect emerging resistance. In the present
survey, the comparison of RR90 and RR50 to distin-
guish susceptible from resistant Þeld populations re-
veals that most of the differences would appear for
ßumethrin. Indeed, because of the smaller slopes of
the Þeld populations (Fig. 2a), four of the Þve Argen-
tinean populations diagnosed susceptible to ßume-
thrin based on RR50 were considered highly resistant
based on RR90, with RR90 values between 27.8 (2.2Ð
53.5) and 36.5 (2.7Ð70.3), indicating emerging ßume-
thrin resistance in these populations. Interestingly,
these four populations would also have been consid-
ered resistant based on their survival rate at the DD.
According to the FAO guidelines (FAO 2004) the
percentage of ticks surviving at the DD can be taken
as the percentage of resistance to the acaricide in the
population. Therefore, the interpretation of the re-
sults based on theDD corroborates the observation of
emerging resistance based on RR90.
Table 5. Lethal concentrations (LC50 and LC90) with their 95% CI obtained for the 8 Argentinean (ST21-ST30), 3 South African
(ST11-ST15), and 2 Australian (Curra, Urah) field strains of R. microplus as well as their RR in comparison to the susceptible reference
strain (Mun˜oz) when tested with amitraz
Country Strain
Amitraz
LC50 (95% CI) RR at LC50 (95% CI) LC90 (95% CI) RR at LC90 (95% CI)
Mun˜oz 1.1 (0.9Ð1.3) 18.5 (9Ð28)
ARG ST21 0.9 (0.7Ð1.1) 0.9 (0.7Ð1.1) 1.9 (1.1Ð2.7) 0.1 (0.1Ð0.1)
ST22 1.7 (1.5Ð1.9) 1.6 (1.2Ð2) 4.1 (3.2Ð5) 0.2 (0.1Ð0.4)
ST24 35.4 (27.2Ð43.6) 32.5 (24.1Ð40.8) 79.8 (50.3Ð109.3) 4.3 (2Ð6.6)
ST25 9.8 (7.2Ð12.3) 9.0 (5.9Ð12.1) 39.0 (21.3Ð56.7) 2.1 (0.7Ð3.6)
ST26 1.8 (1.5Ð2) 1.6 (1.2Ð2) 7.8 (5.1Ð10.5) 0.4 (0.2Ð0.7)
ST27 1.0 (1Ð1.1) 1.0 (0.6Ð1.3) 3.9 (3.3Ð4.4) 0.2 (0.1Ð0.4)
ST29 0.8 (0.4Ð1.1) 0.7 (0.5Ð0.9) 2.6 (0.4Ð4.9) 0.1 (0Ð0.2)
ST30 22.4 (18Ð26.8) 20.5 (15.2Ð25.8) 42.5 (30.2Ð54.8) 2.3 (1.1Ð3.5)
SAFR ST11 1.0 (0.8Ð1.1) 0.9 (0.6Ð1.2) 3.1 (2Ð4.3) 0.2 (0Ð0.3)
ST12 1.2 (0.8Ð1.6) 1.1 (0.9Ð1.4) 6.9 (1Ð12.9) 0.4 (0.1Ð0.6)
ST15 3.8 (2.7Ð4.8) 3.5 (2.4Ð4.6) 21.4 (6.3Ð36.6) 1.2 (0.2Ð2.1)
AUS Curra 1.8 (1.1Ð3.5) 1.6 (0.9Ð2.4) 18.3 (8.1Ð85.8) 1.0 (0.3Ð1.7)
Urah 2.3 (1.1Ð2.5) 2.1 (1Ð3.2) 46.9 (9.7Ð26.8) 2.7 (0.1Ð5.2)
Concentrations are expressed in mg/m2.
Fig. 2. DoseÐresponse curves of some Argentinean Þeld populations (gray) in comparison to the susceptible reference
Mun˜oz strain (black) (A) ST22, ST25Ð29 when tested with ßumethrin. (B) ST24, ST25, and ST30 when tested with amitraz.
The gray dotted horizontal lines indicate 50 and 90% mortalities.
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Similarly to ßumethrin, one population appeared
resistant tomoxidectin in Argentina when using RR90
(ST22, RR90 6.6, 3.0Ð10.2) and another population
appeared resistant to ivermectin in South Africa
(ST15,RR906.8,0.9Ð14.4) although the latter case
was not signiÞcant because of lack of replicates. Even
though these last twocases are isolated, becauseall the
other tick populations were susceptible to ML, they
should be considered with care. Indeed, RR90 should
help detecting emerging resistance and therefore sug-
gest here that ML resistance might be appearing.
However, no history ofML-treatmentwas reported in
the farms from which these ticks were collected.
Therefore,weare lackingadirect correlationbetween
in vitro-Þnding and in vivo-situation and to our knowl-
edgenoresistance toMLhaseverbeenreported in the
literature in Argentina and South Africa.
Conversely, for amitraz, RR90weremuch lower than
RR50andtwoof thethreeresistantpopulationsbasedon
RR50would have been considered susceptible based on
RR90. Unlike with ßumethrin, slopes of the response to
amitraz were greater among the resistant populations
comparedwith thereferencestrain(Fig. 2b).Therefore,
amitraz resistance would have been missed considering
RR90, indicating that RR90 are inadequate values to
identify amitraz resistance.
In Argentina, resistance to SP was detected in seven
out of eight populations (88%), contrasting with the SP
resistance average rate of 23% obtained in populations
from 11 Argentinean provinces reported by Gugliel-
mone et al. (2006). Although farms in the current study
were selected based on reports of lack of treatment
efÞcacy, it indicates that SP resistance is widespread in
Northeast Argentina (Province of Corrientes). The cur-
rent use of SP for tick-treatments was reported in only
three of these farms (ST22, ST29, and ST30). However,
anearlieruseof thisclasscannotbeexcludedintheother
farms. In contrast, resistance toOPwas found in a single
Argentinean population (ST27). This class of com-
poundswasnot reported tobeused for treatmentby the
farmers but OPs have been used in the province before
SPs, and lackofefÞcacywas reportedat that time(Grillo
Torrado andGutie´rrez 1970). TheLTT identiÞed a high
resistance to amitraz in ST24 and conÞrmed the lack of
efÞcacy observed in vivo before tick collection. Resis-
tance to amitraz was also observed in another farmwith
a history of amitraz treatment (ST25) and in a farm
located in the close neighborhood of the above men-
tioned farm and between which the animals are free to
move (ST30, being close to ST24). This survey supports
the very recent Þrst report of amitraz resistance in Ar-
gentina (Cutulle´ et al. 2013). Amitraz resistance in Ar-
gentina is worrying because this compound currently
plays a major role in the eradication program of ticks in
thiscountry. InArgentina, tickcontrol isregulatedbythe
SENASA (Animal Health Authorities) through a law
(12.566)andadecree(7623/54)thatdividethenorthern
part of the country (endemic area) in three areas (SE-
NASA 1938): an infested area, where there is no obliga-
tionoferadication;a tickfreearea,wherethepercentage
of infestedÞelds shouldnot exceed1%; andbetween the
two, an eradication area, where treatments are compul-
sory, aiming to reach eradication. This tick control pro-
gram has been in progress for 70 yr and is based on
treatments in dipping vats at a 21-d interval (resolution
27/1999) (SENASA 1999). This led to the development
of resistance to most of the existing compounds used in
dipping vats. Since 1999 injectable (ML) and pour-on
(ßuazuron) compounds are allowed to be used in com-
binationwithplungedippingoralone(J.Reggi, personal
communication). However, amitraz is currently the
mainactive ingredientused for treatmentbecauseof the
lackof efÞcacyof theother compoundsused for dipping
vats, hence the important impact of the development of
amitraz resistance.
In South Africa, resistance of Boophilus spp. to OP,
SP, and amitraz is well known (Kemp et al. 1998,
StrydomandPeter 1999), but tickswere not identiÞed
at the species level in these previous studies. A na-
tional survey carried out on randomly selected com-
mercial farms showed resistance prevalence of 33, 22,
and 7% to OP, SP, and amidines, respectively (Kemp
et al. 1998). In the current study, one sample of ticks
was collected from a commercial farm, while the two
other samples originated from two herds grouping
cattle of different owners and pasturing on communal
lands, according to the local African traditions. In
these herds the state veterinary authorities offer a
weekly amitraz dip, and cattle owners are free to bring
their animals for the treatments or to perform any
other treatments. Therefore, we do not know exactly
to which active ingredients the cattle from which the
ticks were collected had been exposed. None of the
three populations demonstrated resistance to OP or
amitraz while one population (ST15) demonstrated
resistance to SP and pyriprol and a suspicion of iver-
mectin resistance. The observation of pyriprol resis-
tance, reinforced by a RR50 to Þpronil very close to
our cut-off value of 4.0 (RR50  3.9, 3.3Ð4.6) would
suggest that somePYZ compounds have been used for
treatments; however, pyriprol is not meant to be used
for cattle but is exclusively recommended to treat tick
infestations in dogs and the probability that these
formulations have been used for cattle is very low.
However, it cannot be excluded that other products of
the PYZ class, such as phytosanitary products, have
been used on animals or for plant protection.
In Queensland, Australia, prevalence of resistance
to OP was reported to be between 12 and 96% de-
pending on the regions in 1981 (Roulston et al. 1981).
In the same state, prevalence of resistance to ßume-
thrin and to amitraz was estimated to be 76 and 10%,
respectively, in 2000 (Jonsson et al. 2000). The two
Australian populations analyzed in the present survey
also originated from Queensland and demonstrated
the twomost common resistance in their country, that
is, OP and SP resistance, while they were susceptible
to amitraz and all the other tested compounds.
Although some authors hypothesized thatR. micro-
plus from Australia may be a different species from R.
microplus from Africa and Latin America (Labruna et
al. 2009), this study indicate that acaricidal resistance
was comparable between the three selected countries
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and that resistancecouldbeestimatedcomparingAus-
tralian Þeld populations to aMexican reference strain.
In the current study, the cut-off value of four was
selected to distinguish resistant from susceptible ticks
based on RR. Lower threshold values have been pre-
viouslyused(Chevillonet al. 2007,Mendes et al. 2007)
while in other studies, RR were separated into three
classes among which RR of the intermediate class
were considered as indicators of tolerance or of in-
cipient resistance (Bianchi et al. 2003, CastroÐJaner et
al. 2011, Klafke et al. 2012). The cut-off value of four
should avoid over-diagnosing resistance. Conversely,
one could argue that resistance may be missed. How-
ever, if we had selected a threshold value of three
instead of four, resistance statuses would have been
identical in 96% of the cases and only four additional
cases would have been considered resistant. There-
fore, we are conÞdent that this threshold value offers
a good compromise to differentiate susceptible from
resistant populations.
The use of DD to determine whether resistance is
present is widespreadwith adult tests such as the AIT,
but has been criticized (Jonsson et al. 2007). It offers
the beneÞt to reduce the number of engorged females
required for testing and the amount of work since a
single dose of each compound is tested. Although the
beneÞt of testing a single dose per compoundwith the
LTT is very much reduced, we were interested to see
whether the use of DD would be suitable to detect
resistance in the current study. A survival rate of ticks at
the DD of 10% was used to differentiate resistant from
susceptible tick populations. Resistance statuses based
on DD using this cut-off value were in agreement with
those based on RR50 or RR90 and the use of DD, there-
fore, appeared to be adequate to diagnose established
and emerging resistance in these Þeld populations.
To conclude, the LTT allowed the detection of
resistance in Þeld populations of R. microplus ticks
originating from Argentina, South Africa, and Austra-
lia. Resistance statuses were based on RR50, using a
cut-off value of four to differentiate susceptible from
resistant populations. In addition,RR90were also con-
sidered todetect emerging resistance. Finally, survival
rates at DD were compared with the resistance sta-
tuses based onRR50 andRR90. Three cases of amitraz
resistance in Argentina were identiÞed as well as the
Þrst case of resistance to pyriprol in South Africa. In
addition, emerging resistance to ML was suspected in
an Argentinean and a South African farm. For this
study, ticks were imported to Switzerland for testing.
However, in the future, we would like the LTT to be
performed in laboratories of the countries of collec-
tion. To do so, a detailed description of the test using
simpliÞed equipment has been published recently
(Lovis et al. 2013).
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